Filing Flows › Alamar Biosciences (ALMR) › R&D spending
Alamar Biosciences (ALMR) R&D spending by quarter
Alamar Biosciences' R&D spending was $16.2M in Q3 2026 (third quarter 2026), +17% from Q2 2026. Over the last 3 quarters it ranged from $13.0M (Q1 2026) to $16.2M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.2M | +17% | — |
| Q2 2026 | $13.8M | +6% | — |
| Q1 2026 | $13.0M | — | — |
Q3 2026 at a glance
Alamar Biosciences, Q3 2026: revenue $33.5M (+68% year over year), operating margin -45.1%, net loss $13.3M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Alamar Biosciences' R&D spending?
Alamar Biosciences' R&D spending was $16.2M in Q3 2026 (third quarter 2026), +17% from Q2 2026.
How has Alamar Biosciences' R&D spending changed?
Over the last 3 quarters it ranged from $13.0M (Q1 2026) to $16.2M (Q3 2026).